GRI Bio, Inc.
GRI
$1.46
-$0.05-3.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.79% | 0.70% | 66.65% | 12.23% | 11.68% |
| Total Depreciation and Amortization | -171.05% | -97.50% | -18.18% | 15.38% | -392.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -100.00% |
| Total Other Non-Cash Items | 282.88% | -81.57% | -189.22% | 169.23% | -131.71% |
| Change in Net Operating Assets | 97.04% | -136.53% | -94.89% | -195.31% | -482.81% |
| Cash from Operations | 64.05% | -73.00% | -39.03% | -280.48% | -558.77% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -59.55% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -102.47% | -- | 91.26% | -371.63% | 3,229.03% |
| Cash from Financing | -41.21% | -- | -25.21% | 335.53% | 415.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.79% | -22.58% | -47.87% | 406.21% | -1,668.42% |